NEW YORK, May 1 - DNA Sciences today said it has opened a lab in the UK to help bring the firm closer to its European clientele.

The lab, based in Cambridge, currently employs five staff and will conduct gene-based candidate discovery.

Mark Littlewood, a four-year veteran of DNA Sciences, will run the lab's DNA purification, banking, and genotyping operations. Trevor Brett, a company newcomer, will oversee business development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.